RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Condition(s):Diffuse Large B-cell LymphomaLast Updated:April 2, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Diffuse Large B-cell LymphomaLast Updated:April 2, 2018Completed
Condition(s):Esophageal Squamous Cell NeoplasmLast Updated:March 3, 2023Recruiting
Condition(s):Dupuytren Contracture; Dupuytren’s Disease; Contracture; Joint Diseases; Musculoskeletal Diseases; Fibroma; Neoplasm, Fibrous Tissue; Neoplasms, Connective Tissue; Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type; Neoplasms; Connective Tissue DiseasesLast Updated:May 17, 2023Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:January 19, 2024Recruiting
Condition(s):Adult Acute Lymphocytic LeukemiaLast Updated:March 17, 2023Completed
Condition(s):Carpal Tunnel Syndrome; TenosynovitisLast Updated:April 28, 2020Completed
Condition(s):Pediatric Hodgkin’s DiseaseLast Updated:March 20, 2024Recruiting
Condition(s):Prostate CancerLast Updated:August 17, 2012Terminated
Condition(s):Diabetes Mellitus, Type 1Last Updated:March 30, 2023Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:February 28, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.